Literature DB >> 27865275

Imaging Evaluation of Pancreatic Cancer.

Myra Kay Feldman1, Namita Sharma Gandhi2.   

Abstract

Imaging studies are critical for the detection, characterization, initial staging, management, and monitoring of pancreatic cancer cases. Treatment of pancreatic cancer requires a multidisciplinary approach. Ideally, assessing resectablility with imaging and subsequent treatment decisions should be made at a high-volume center of excellence with a multidisciplinary team. This article reviews the major imaging modalities used to evaluate pancreatic neoplasms, with an emphasis on pancreatic imaging protocols. The imaging appearance of solid pancreatic neoplasms and the imaging criteria used to stage and determine resectability for pancreatic ductal adenocarcinoma are described. An approach to standardized radiologic reporting is also reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; MRI; Pancreatic cancer; Pancreatic imaging; Resectability; Structured radiologic reports

Mesh:

Year:  2016        PMID: 27865275     DOI: 10.1016/j.suc.2016.07.007

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

Review 1.  Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer.

Authors:  Pujan Kandel; Michael B Wallace
Journal:  Cancers (Basel)       Date:  2018-02-17       Impact factor: 6.639

2.  Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer.

Authors:  Steffi J E Rombouts; Tyche C Derksen; Chung Y Nio; Richard van Hillegersberg; Hjalmar C van Santvoort; Marieke S Walma; Izaak Q Molenaar; Maarten S van Leeuwen
Journal:  Abdom Radiol (NY)       Date:  2018-10

3.  Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.

Authors:  Xinchun Liu; Yue Fu; Qiuyang Chen; Junli Wu; Wentao Gao; Kuirong Jiang; Yi Miao; Jishu Wei
Journal:  BMC Gastroenterol       Date:  2018-11-06       Impact factor: 3.067

4.  Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis.

Authors:  Giorgia Arcovito; Iosè Di Stefano; Laura Boldrini; Francesca Manassero; Jacopo Durante; Alessio Tognarelli; Pinuccia Faviana
Journal:  Medicina (Kaunas)       Date:  2020-12-18       Impact factor: 2.430

5.  18F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model.

Authors:  Xiaohui Wang; Jun Zhang; Zhijian Han; Liheng Ma; Yumin Li
Journal:  J Cancer       Date:  2022-03-21       Impact factor: 4.207

6.  Reclassification of lesions in biopsies by fine-needle aspiration of pancreas and biliary tree using Papanicolaou classification.

Authors:  Adriana N López-Ramírez; Lidia F Villegas-González; Mónica L Serrano-Arévalo; Lorena Flores-Hernández; Leonardo S Lino-Silva; Ludwig E González-Mena
Journal:  J Gastrointest Oncol       Date:  2018-10

7.  Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.

Authors:  Po-Ting Chen; Dawei Chang; Huihsuan Yen; Kao-Lang Liu; Su-Yun Huang; Holger Roth; Ming-Shiang Wu; Wei-Chih Liao; Weichung Wang
Journal:  Radiol Imaging Cancer       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.